1302 related articles for article (PubMed ID: 17292571)
1. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
2. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
Chin BS; Futaba K; Jethwa A; Lip GY
Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
8. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
9. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
10. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
13. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
14. Influence of hormone replacement therapy on C-reactive protein: population-based data.
Primatesta P; Falaschetti E; Poulter NR
J Cardiovasc Risk; 2003 Feb; 10(1):57-60. PubMed ID: 12569237
[TBL] [Abstract][Full Text] [Related]
15. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
[TBL] [Abstract][Full Text] [Related]
17. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
18. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
Wise MR; Stewart DE; Liu P; Abramson BL
CMAJ; 1999 Jul; 161(1):33-6. PubMed ID: 10420861
[TBL] [Abstract][Full Text] [Related]
19. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
20. Use of hormone replacement therapy in Italian women aged 50-70 years.
Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
